Correlation Between CirChem AB and KABE Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CirChem AB and KABE Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CirChem AB and KABE Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CirChem AB and KABE Group AB, you can compare the effects of market volatilities on CirChem AB and KABE Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CirChem AB with a short position of KABE Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of CirChem AB and KABE Group.

Diversification Opportunities for CirChem AB and KABE Group

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between CirChem and KABE is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding CirChem AB and KABE Group AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KABE Group AB and CirChem AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CirChem AB are associated (or correlated) with KABE Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KABE Group AB has no effect on the direction of CirChem AB i.e., CirChem AB and KABE Group go up and down completely randomly.

Pair Corralation between CirChem AB and KABE Group

Assuming the 90 days trading horizon CirChem AB is expected to generate 2.14 times less return on investment than KABE Group. In addition to that, CirChem AB is 2.48 times more volatile than KABE Group AB. It trades about 0.01 of its total potential returns per unit of risk. KABE Group AB is currently generating about 0.06 per unit of volatility. If you would invest  19,135  in KABE Group AB on September 3, 2024 and sell it today you would earn a total of  10,765  from holding KABE Group AB or generate 56.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

CirChem AB  vs.  KABE Group AB

 Performance 
       Timeline  
CirChem AB 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CirChem AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, CirChem AB sustained solid returns over the last few months and may actually be approaching a breakup point.
KABE Group AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days KABE Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, KABE Group is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

CirChem AB and KABE Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CirChem AB and KABE Group

The main advantage of trading using opposite CirChem AB and KABE Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CirChem AB position performs unexpectedly, KABE Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KABE Group will offset losses from the drop in KABE Group's long position.
The idea behind CirChem AB and KABE Group AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance